QIAGEN N.V., NL0012169213

QIAGEN N.V., NL0012169213

29.08.2017 - 10:25:28

QIAGEN N.V.: Release of a capital market information

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 (MAR) and the Delegated EU Regulation 2016/1052 QIAGEN N.V. Share Repurchase

- Interim Reporting

On August 9, 2017, QIAGEN N.V. disclosed pursuant to Article 5 Section (1), (2) and (6) of the EU Regulation no 596/2014 and the Delegated EU Regulation no 2016/1052 the beginning of a share buyback program for USD 60 million for the following day.

The total number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from August 10, 2017 until and including August 25, 2017 amounts to 913,686 shares.

The purchase of the shares of QIAGEN N.V. is carried out by a financial institution that has been commissioned by QIAGEN N.V..

Further information regarding the transactions according to Article 5 Section (1), (2) and (6) of the EU Regulation no 596/2014 and the Delegated EU Regulation no 2016/1052 is published on the website of QIAGEN N.V. (www.qiagen.com).

Venlo, 29 August 2017

The Managing Board

###

Contacts:

QIAGEN Investor Relations John Gilardi +49 2103 29 11711 e-mail: ir@qiagen.com

Public Relations Dr. Thomas Theuringer +49 2103 29 11826 e-mail: pr@qiagen.com

29.08.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: QIAGEN N.V. Hulsterweg 82 5912 PL Venlo

Netherlands Internet: www.qiagen.com   End of News DGAP News Service

604867  29.08.2017 

@ dgap.de